Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

miR-26b-5p in macrophage exosomes helps keloids grow.

High DKK1 levels predict worse survival in head and neck cancer.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

A specific group of slow-growing stem cells marked by Thy1 is crucial for skin maintenance and healing in mice.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Deep skin fibroblasts help recruit immune cells for better wound healing.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

PCFCL may have unrecognized subtypes and needs more research.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.